Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000043 |
|---|---|
| Form Type | 4 |
| Filing Date | May 22, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
229,520
Total Value
$6,686,170.87
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 38,689 | $6.84 | $264,632.76 | 155,172 | Direct | โ | View Details | |
Director | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 11,904 | $7.80 | $92,851.20 | 167,076 | Direct | โ | View Details | |
Director | Common Stock | โ | May 21, 2026 | Exercise/Conversion | 11,667 | $11.77 | $137,320.59 | 178,743 | Direct | โ | View Details | |
Director | Common Stock | โ | May 21, 2026 | Sale | 38,318 | $58.43 | $2,238,794.29 | 140,425 | Direct | โ | View Details | |
Director | Common Stock | โ | May 21, 2026 | Sale | 53,447 | $59.10 | $3,158,910.11 | 86,978 | Direct | โ | View Details | |
Director | Common Stock | โ | May 21, 2026 | Sale | 13,235 | $59.97 | $793,661.92 | 73,743 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 21, 2026 | Exercise/Conversion | 38,689 | $0.00 | $0.00 | 32,737 | Direct | โ | View Details | |
Director | Warrant (right to buy) | Derivative | May 21, 2026 | Exercise/Conversion | 11,904 | $0.00 | $0.00 | 10,952 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | May 21, 2026 | Exercise/Conversion | 11,667 | $0.00 | $0.00 | 5,833 | Direct | โ | View Details |